Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells
Open Access
- 16 September 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 31, 101109
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceutical Company
- Kyoto University
- Takeda Pharmaceuticals North America
This publication has 66 references indexed in Scilit:
- An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood CellsStem Cells, 2013
- Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitnessJournal of Clinical Investigation, 2012
- A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR ExpressionMolecular Therapy Nucleic Acids, 2012
- Cancer and Radiation Therapy: Current Advances and Future DirectionsInternational Journal of Medical Sciences, 2012
- A human memory T cell subset with stem cell–like propertiesNature Medicine, 2011
- Structural Basis of Specificity and Cross-Reactivity in T Cell Receptors Specific for Cytochrome c–I-EkThe Journal of Immunology, 2011
- A more efficient method to generate integration-free human iPS cellsNature Methods, 2011
- T Cell ActivationAnnual Review of Immunology, 2009
- Prospero‐related homeobox 1 and liver receptor homolog 1 coordinately regulate long‐term proliferation of murine fetal hepatoblasts†Hepatology, 2008
- Disruption of Extracellular Interactions Impairs T Cell Receptor-CD3 Complex Stability and SignalingImmunity, 2007